Business Standard |
Rolls-Royce grows an Indian heart
Business Standard One of the world’s first ultra-luxury brands is going strong for over 100 years and is even considering an India edition of its product. Rolls-Royce Motors, the automobile arm of Rolls-Royce, and now owned by BMW, announced its designs on India on the … |
Adult Stem Cells, The Future of Medicine: One Patient's Story – LifeNews.com
|
Adult Stem Cells, The Future of Medicine: One Patient’s Story
LifeNews.com Tony applied and was accepted into a similar clinical trial underway with Dr. Richard Burt at Northwestern University in Chicago. Missy says it was miraculous to see the adult stem cells go to work: “When he received the adult stem cell transplant, the … |
Patients with recurrent HCV benefit from triple therapy after liver transplant – Healio
Patients with recurrent HCV benefit from triple therapy after liver transplantHealioIn a multicenter cohort study in France, researchers evaluated 37 patients with recurrent hepatitis C genotype 1 who underwent liver transplantation (LT) and received t…
Max Super Speciality Hospital saves elderly's lif – Times of India
|
Max Super Speciality Hospital saves elderly’s lif
Times of India In conventional practice where a heart-lung machine took over the function of patient’s heart and lungs during the surgery, an Octopus Tissue Stabilizer (OTS), which was designed to position and to hold the heart, gave the surgeon easy access to the … |
Biosimilar Opportunities in an Evolving Market – New Report Available – SBWire (press release)
|
Biosimilar Opportunities in an Evolving Market – New Report Available
SBWire (press release) In terms of revenue, six of the top ten pharmaceutical therapies are biological products, which have been targeted by biosimilar developers: Abbvie’s Humira (adalimumab), Roche’s MabThera (rituximab), Herceptin (trastuzumab) and Avastin (bevacizumab), … |
Children's Hospital of Philadelphia Becomes First Accredited Pediatric Heart … – eReleases (press release)
|
Children’s Hospital of Philadelphia Becomes First Accredited Pediatric Heart …
eReleases (press release) “The heart failure program at The Children’s Hospital of Philadelphia is enthusiastic about working with the Colloquium,” said Dr. Joseph Rossano, Medical Director of Heart Transplantation. “Working together with other Children’s Hospitals throughout … |
Children's Hospital of Philadelphia Becomes First Accredited Pediatric Heart … – PR Newswire (press release)
|
Children’s Hospital of Philadelphia Becomes First Accredited Pediatric Heart …
PR Newswire (press release) 16, 2013 /PRNewswire/ — The Healthcare Accreditation Colloquium announced today that Children’s Hospital of Philadelphia (CHOP) became the first Accredited Pediatric Heart Failure Institute in Pennsylvania and third in the nation following nearly a … |
Fc Protein and Glycoengineered Antibodies Market, 2013 – 2023 – MarketWatch (press release)
Fc Protein and Glycoengineered Antibodies Market, 2013 – 2023MarketWatch (press release)Engineered antibodies are antibody based therapeutics, which are gaining increasing attention from both large and small pharmaceutical companies. Developed through …
Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas – 24/7 Wall St.
Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas24/7 Wall St.Biogen also is partnering with AbbVie Inc. (NYSE: ABBV) in Phase III trials for Daclizumab. Credit Suisse has a $255 dollar price target on this top name. The consen…
Cancer drug has potential to treat diabetes – Times of India
Times of IndiaCancer drug has potential to treat diabetesTimes of IndiaThe studies, done in mice, identify a previously unexpected link between a low-oxygen condition called hypoxia and the ability of cells in the liver to respond to insulin. The drug,…